🚀 VC round data is live in beta, check it out!
Vitrafy Valuation Multiples
Discover revenue and EBITDA valuation multiples for Vitrafy and similar public comparables like ArcticZymes, 4basebio, Pacific Edge, SDI Group and more.
Vitrafy Overview
About Vitrafy
Vitrafy Life Sciences Ltd developed a range of proprietary smart cryopreservation hardware devices and Lifechain, an integrated, cloud-based software platform, to provide a complete, vertically integrated cryopreservation solution to retain the quality of cryopreserved biomaterials. The company devices includes Vitrafy’s Smart Cryopreservation Device; Vitrafy’s Smart Thawing Device and Vitrafy’s Smart Packaging.
Founded
2017
HQ
Employees
N/A
Website
Sectors
Financials (LTM)
EV
$69M
Vitrafy Financials
Vitrafy reported last 12-month revenue of $1M and negative EBITDA of ($12M).
In the same LTM period, Vitrafy generated ($12M) in EBITDA losses and had net loss of ($14M).
Revenue (LTM)
Vitrafy P&L
In the most recent fiscal year, Vitrafy reported revenue of $47K and EBITDA of ($9M).
Vitrafy expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1M | XXX | $47K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $47K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 100% | XXX | XXX | XXX |
| EBITDA | ($12M) | XXX | ($9M) | XXX | XXX | XXX |
| EBITDA Margin | (1102%) | XXX | (19043%) | XXX | XXX | XXX |
| EBIT Margin | (1107%) | XXX | (19112%) | XXX | XXX | XXX |
| Net Profit | ($14M) | XXX | ($21M) | XXX | XXX | XXX |
| Net Margin | (1294%) | XXX | (45301%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Vitrafy Stock Performance
Vitrafy has current market cap of $85M, and enterprise value of $69M.
Market Cap Evolution
Vitrafy's stock price is $1.33.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $69M | $85M | 0.0% | XXX | XXX | XXX | $-0.33 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVitrafy Valuation Multiples
Vitrafy trades at 64.0x EV/Revenue multiple, and (5.8x) EV/EBITDA.
EV / Revenue (LTM)
Vitrafy Financial Valuation Multiples
As of April 19, 2026, Vitrafy has market cap of $85M and EV of $69M.
Equity research analysts estimate Vitrafy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Vitrafy has a P/E ratio of (6.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $85M | XXX | $85M | XXX | XXX | XXX |
| EV (current) | $69M | XXX | $69M | XXX | XXX | XXX |
| EV/Revenue | 64.0x | XXX | 1475.4x | XXX | XXX | XXX |
| EV/EBITDA | (5.8x) | XXX | (7.7x) | XXX | XXX | XXX |
| EV/EBIT | (5.8x) | XXX | (7.7x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1475.4x | XXX | XXX | XXX |
| P/E | (6.1x) | XXX | (4.0x) | XXX | XXX | XXX |
| EV/FCF | (6.6x) | XXX | (12.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Vitrafy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Vitrafy Margins & Growth Rates
Vitrafy's revenue in the last 12 month grew by 273%.
Vitrafy's rule of 40 is (55%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Vitrafy's rule of X is 449% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Vitrafy Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 273% | XXX | 2751% | XXX | XXX | XXX |
| EBITDA Margin | (1102%) | XXX | (19043%) | XXX | XXX | XXX |
| EBITDA Growth | (5%) | XXX | 42% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (55%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 449% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 46% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 519% | XXX | 11228% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 604% | XXX | 10080% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 25547% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Vitrafy Public Comps
See public comps and valuation multiples for other Life Sciences Tools comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Vitrafy | XXX | XXX | XXX | XXX | XXX | XXX |
| ArcticZymes | XXX | XXX | XXX | XXX | XXX | XXX |
| 4basebio | XXX | XXX | XXX | XXX | XXX | XXX |
| Pacific Edge | XXX | XXX | XXX | XXX | XXX | XXX |
| SDI Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Insight Molecular | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Vitrafy M&A Activity
Vitrafy acquired XXX companies to date.
Last acquisition by Vitrafy was on XXXXXXXX, XXXXX. Vitrafy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Vitrafy
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialVitrafy Investment Activity
Vitrafy invested in XXX companies to date.
Vitrafy made its latest investment on XXXXXXXX, XXXXX. Vitrafy invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Vitrafy
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Vitrafy
| When was Vitrafy founded? | Vitrafy was founded in 2017. |
| Where is Vitrafy headquartered? | Vitrafy is headquartered in Australia. |
| Is Vitrafy publicly listed? | Yes, Vitrafy is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Vitrafy? | Vitrafy trades under VFY ticker. |
| When did Vitrafy go public? | Vitrafy went public in 2024. |
| Who are competitors of Vitrafy? | Vitrafy main competitors are ArcticZymes, 4basebio, Pacific Edge, SDI Group. |
| What is the current market cap of Vitrafy? | Vitrafy's current market cap is $85M. |
| What is the current revenue of Vitrafy? | Vitrafy's last 12 months revenue is $1M. |
| What is the current revenue growth of Vitrafy? | Vitrafy revenue growth (NTM/LTM) is 273%. |
| What is the current EV/Revenue multiple of Vitrafy? | Current revenue multiple of Vitrafy is 64.0x. |
| Is Vitrafy profitable? | No, Vitrafy is not profitable. |
| What is the current EBITDA of Vitrafy? | Vitrafy has negative EBITDA and is not profitable. |
| What is Vitrafy's EBITDA margin? | Vitrafy's last 12 months EBITDA margin is (1102%). |
| What is the current EV/EBITDA multiple of Vitrafy? | Current EBITDA multiple of Vitrafy is (5.8x). |
| What is the current FCF of Vitrafy? | Vitrafy's last 12 months FCF is ($10M). |
| What is Vitrafy's FCF margin? | Vitrafy's last 12 months FCF margin is (973%). |
| What is the current EV/FCF multiple of Vitrafy? | Current FCF multiple of Vitrafy is (6.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.